In fact, MSC and MSC-CM is capable of activating Wnt signaling in cholangiocarcinoma cells by promoting the nuclear translocation of β-catenin, and upregulated Wnt target genes including MMPs family, cyclin D1 and c-Myc [25]. The gene discussed is CCND1; the disease is cholangiocarcinoma.